Back to Rankings

EVAX

Evaxion A/SA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
EVAX vs peer average
87/100
EVAX vs. peer average (A vs. C)
Grade spread
A 1 · B 2 · C 3 · D 1 · F 3
Graded peers loaded
Coverage
10 graded
91% of tracked

Peer overview

BTAI is the first available peer comparator.

BioXcel is another micro-cap biotech where pipeline updates and financing headlines can dominate trading, making it a useful event-volatility comparator even though it is not a close scientific peer.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerBTAIBioXcel Therapeutics
EVAX
Evaxion A/S
BTAI
BioXcel Therapeutics
Grade
A
F
Momentum
84
10
Value
44
41
Sentiment
77
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Defensive

Grade position vs BTAI

EVAX / BTAI
Grade Position
Above peers
EVAX vs. peer average (A vs. C)
87/100
Momentum
84
EVAX
Value
44
EVAX
Sentiment
77
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs EVAX
1
BTAI
BTAI
F
20/100
+4
2
RVPH
RVPH
-
-
-
3
VERU
VERU
F
20/100
+4
4
APLM
Apollomics Inc Class A Common
B
80/100
+1
5
LSTA
Lisata Therapeutics Inc Common
D
40/100
+3
BTAI is the first peer returned for this comparison set.